About Norbert Riedel
Norbert Riedel is a chairman of the board at Neela Therapeutics.
Form D filings also name Norbert Riedel as a director at Alcyone Therapeutics.
Norbert Riedel first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Norbert Riedel in the role, so the role may have started earlier or lasted longer.
Neela Therapeutics, Inc.
Chairman of the Board
2025 – 2026 · Lunenburg, MA
Develops precision therapies for children with rare and serious diseases.
Key Colleagues at Startups
The people Norbert Riedel works with at each company, as listed on that company's latest Form D.
Neela Therapeutics, Inc. · Form D/A, May 26, 2026
RU
Richard Upton
Partner, Harbor Light Capital Partners and director
EJ
Edgar Jannotta Jr.
Board Observer
DD
David Donabedian
Founding CEO, Newleos Therapeutics and director
PA
Pj Anand
Founder, President and Chief Executive Officer, director
SO
Stephen Oesterle
Director
Alcyone Therapeutics, Inc. · Form D/A, Jan 8, 2025
EJ
Edgar Jannotta
Director
DD
David Donabedian
Director
SO
Stephen Oesterle
Director
PA
Pj Anand
Chief Executive Officer and director
RU
Richard Upton
Director
CD
Cameron Durrant
Director